ATE224706T1 - Verbesserte darreichung von antikrebsmittel an feste tumore mittels primer-verbindungen - Google Patents

Verbesserte darreichung von antikrebsmittel an feste tumore mittels primer-verbindungen

Info

Publication number
ATE224706T1
ATE224706T1 AT98930728T AT98930728T ATE224706T1 AT E224706 T1 ATE224706 T1 AT E224706T1 AT 98930728 T AT98930728 T AT 98930728T AT 98930728 T AT98930728 T AT 98930728T AT E224706 T1 ATE224706 T1 AT E224706T1
Authority
AT
Austria
Prior art keywords
solid tumors
agents
primer
agent
camp
Prior art date
Application number
AT98930728T
Other languages
English (en)
Inventor
Kristofer Rubin
Mats Sjoequist
Rolf Reed
Original Assignee
Biophausia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophausia Ab filed Critical Biophausia Ab
Application granted granted Critical
Publication of ATE224706T1 publication Critical patent/ATE224706T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT98930728T 1997-06-02 1998-05-26 Verbesserte darreichung von antikrebsmittel an feste tumore mittels primer-verbindungen ATE224706T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702086A SE9702086D0 (sv) 1997-06-02 1997-06-02 Anti-cancer drug delivery to solid tumors
PCT/EP1998/003078 WO1998055112A1 (en) 1997-06-02 1998-05-26 Enhanced anti-cancer agent delivery to solid tumors by primer compounds

Publications (1)

Publication Number Publication Date
ATE224706T1 true ATE224706T1 (de) 2002-10-15

Family

ID=20407206

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930728T ATE224706T1 (de) 1997-06-02 1998-05-26 Verbesserte darreichung von antikrebsmittel an feste tumore mittels primer-verbindungen

Country Status (12)

Country Link
US (1) US6303660B1 (de)
EP (1) EP0977559B1 (de)
JP (1) JP2002502399A (de)
AT (1) ATE224706T1 (de)
AU (1) AU733882B2 (de)
CA (1) CA2292699A1 (de)
DE (1) DE69808270T2 (de)
DK (1) DK0977559T3 (de)
ES (1) ES2184289T3 (de)
PT (1) PT977559E (de)
SE (1) SE9702086D0 (de)
WO (1) WO1998055112A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630120B1 (en) * 1999-03-08 2003-10-07 Alkermes, Inc. Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors
JP2005510501A (ja) * 2001-10-19 2005-04-21 マキシム ファーマシューティカルス，インコーポレイテッド 肝臓疾患治療へのヒスタミンの使用
EP2296678A4 (de) * 2008-05-27 2012-03-21 Oncolytics Biotech Inc Modulation des interstitiellen drucks sowie onkolytische virenfreisetzung und -verteilung
JP2015144904A (ja) * 2015-04-20 2015-08-13 佐藤　洋 位置制御システム
EA201991555A1 (ru) * 2016-12-22 2020-01-23 Мавуфарма, Инк. Композиции и способы усиления или увеличения продукции ifn i типа

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751224A (en) * 1983-07-21 1988-06-14 Brown University Research Foundation Treatment of metastasis
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4654366A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicyclo[2.2.1]heptane substituted ethers useful as anti-thrombotic agents

Also Published As

Publication number Publication date
JP2002502399A (ja) 2002-01-22
US6303660B1 (en) 2001-10-16
SE9702086D0 (sv) 1997-06-02
DE69808270T2 (de) 2003-05-22
PT977559E (pt) 2003-02-28
EP0977559A1 (de) 2000-02-09
AU733882B2 (en) 2001-05-31
ES2184289T3 (es) 2003-04-01
WO1998055112A1 (en) 1998-12-10
EP0977559B1 (de) 2002-09-25
CA2292699A1 (en) 1998-12-10
DK0977559T3 (da) 2003-01-27
DE69808270D1 (de) 2002-10-31
AU8106198A (en) 1998-12-21

Similar Documents

Publication Publication Date Title
EP0301639A3 (de) Analoge von das Bradykinin verstärkendem Peptid BPP 5a und Methode zu deren Herstellung
PT771147E (pt) Composições e métodos para imunidade celular tumoral in vivo melhorada
US8557829B2 (en) Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
YU76100A (sh) Pirolo(2,3-d) pirimidin preparati i njihova primena
WO2005086798A3 (en) Improved interleukin-2 muteins
EP1354598A3 (de) Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2
WO2005055948A3 (en) Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
BR0108025A (pt) Compostos de amida, sal farmaceuticamente aceitável de um metabólito farmaceuticamente ativo do composto, composição farmacêutica para modular ou inibir a atividade de um receptor de proteìna cinase, método de tratamento de uma condição doentia de mamìferos mediada pela atividade de proteìna cinase e método para modular ou inibir a atividade de um receptor de proteìna cinase
EP0954334A4 (de) Verwendung von Makrophagen-Wanderungs-inhibitorischen Faktor-Antagonisten zur Krebstherapie
TR200003801T2 (tr) Acı hafifletmek için deri üstü kompozisyonlar ve yöntemler
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
Santelli et al. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice
ATE540044T1 (de) Lpa-rezeptor-agonisten und antagonisten und verwendungsverfahren dafür
NO921050D0 (no) Anti-svulst preparat bestaaende av interleukin-2 og histamin, analoger derav eller h2 receptor agonister
ATE224706T1 (de) Verbesserte darreichung von antikrebsmittel an feste tumore mittels primer-verbindungen
DK0952772T3 (da) Fremgangsmåder til anvendelse af mononukleare phagocytter til at fremme axonal regeneration
WO2005011590A3 (en) Compositions and methods for restoring sensitivity to treatment with her2 antagonists
YU77002A (sh) Postupak i preparat za tretiranje kancera putem davanja hemoterapeutskog agensa koji indukuje apoptozis
AU8239298A (en) Nucleotide-comprising composition
Sperlágh et al. Is the neuronal ATP release from guinea-pig vas deferens subject to α2-adrenoceptor-mediated modulation?
NO984124L (no) FremgangsmÕte for Õ hemme adenylsuksinatsyntetaseaktivitet i metyltioadenosinfosforylasemanglende celler
Marshall et al. Effect of choline on basal and stimulated acetylcholine release: an in vivo microdialysis study using a low neostigmine concentration
WO2000061141A3 (en) Methods and compositions for enhancing delivery of therapeutic agents to tissues
WO2005056766A3 (en) TARGETED DRUG DELIVERY USING EphA2 OR Eph4 BINDING MOIETIES
DK0563127T3 (da) Forbedret behandlingsfremgangsmåde til cancer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0977559

Country of ref document: EP

REN Ceased due to non-payment of the annual fee